GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
Mental Health & Behavioral Research | Obesity & Weight Control
What is the purpose of this trial?
If you are between 18 and 55 years of age and are overweight or have obesity you may qualify for a clinical trial evaluating a once weekly medication which may help with weight loss. The SEMA trial is funded by the National Institutes of Health (NIH) and the study medication (semaglutide vs. placebo) is provided at no cost to qualifying participants. Participants with diabetes are not eligible for this study.
- Ages18 years - 55 years
- Trial withNational Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
- Start Date06/25/2020
- End Date06/30/2025
- Last Updated07/15/2021
- Study HIC#2000027868